InsidersTradesSigma
Track the ROIVANT SCIENCES LTD share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €25bn. The latest transaction was filed on 8 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MEGHAN FITZGERALD. All data is openly available.
Analysts rate ROIVANT SCIENCES LTD Strong Buy (bullish), based on 11 analysts. Average price target: US$41.86.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
ROIVANT SCIENCES LTD 是一家生物制药公司，专注于开发治疗严重疾病的创新疗法。它采用技术驱动的方法来加速药物研发。